Wai Yuen Tong Medicine Holdings Limited has issued a positive profit alert, indicating a financial turnaround for the fiscal year ended March 31, 2025. According to a preliminary review of the company's draft unaudited consolidated management accounts, the Group is projected to shift from a loss of approximately HK$15.4 million in the previous year to a profit not exceeding HK$15.0 million. This marks a significant improvement from the loss reported in the financial year ended March 31, 2024. The announcement, which follows regulatory disclosure requirements, highlights that the final financial results are subject to the completion of valuation assessments by independent professional valuers. The detailed annual results are expected to be published by the end of June 2025. The company has advised shareholders and potential investors to exercise caution when trading shares in light of this new financial outlook.